Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.88% is 86% below its 1-year average of 57.39%, near the low end of its 1-year range (5.98%–135.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 74.82% below its 12-month average of 31.28%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.88%.
DEBT TO ASSETS RATIO
7.88%
DEBT TO ASSETS RATIO AVG TTM
31.28%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-74.82%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 657 covered companies
CURRENT VS SECTOR MEDIAN
+7775.16%
vs the sector median at left
Heartflow, Inc. Common Stock
Market Cap
$4.37B
Debt to Assets Ratio
7.88%
TTM Avg
31.28%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.36B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.42B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.45B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.64B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.66B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.08B
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.37B | 7.88% | 31.28% | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | 0.01% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | 0.41% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 0.64% | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.12B | 0.13% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 0.20% | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 0.38% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.66B | 0.09% | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.08B | 0.10% | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | 0.03% | N/A | N/A | N/A |
Debt/Assets
7.9%
Debt/Equity
0.10
Current Ratio
5.08
Interest Coverage
-4.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 7.88% |
| 2026-03-31 | 7.66% |
| 2025-12-31 | 6.14% |
| 2025-09-30 | 5.98% |
| 2025-06-30 | 128.73% |
| 2025-03-31 | 110.21% |
| 2024-12-31 | 135.11% |
